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antibody with an average dye/antibody ratio of 2.20. The signal strength was comparable to the original DyLight649 secondary antibody after slight adjustment to the fluorescent scanner PMT settings.
CF633 succinimidyl ester dye (SCJ4600039) was purchased from Sigma Aldrich (St. Louis, MO). The dye was rehydrated in anhydrous DMSO (100 µL); unconjugated dye was stored at -20 °C.
The anti-human IgM (Jackson Immuno, 109.005.129) was dissolved in PBS (pH 7.4). The reaction solution consisted of the anti-human IgM and rehydrated CF633 dye in an 8.88 dye-to-antibody molar ratio; the manufacturer recommended an antibody concentration of at least 2 mg/mL to optimize labeling. 0.1M sodium bicarbonate was also added to promote the amide linkage formation between the amine group of the antibody and ester of the dye. The reaction vial sat at room temperature for one hour and was inverted every 15 minutes. The procedure from the AlexaFluor Antibody Labeling Kits was used to purify the conjugated IgM antibodies from the free dye. Degree of labeling was calculated using absorbance readings at 280 and 630 nm via the NanoDrop2000 and the formula provided by SigmaAldrich. The secondary reagent used in our experiments had an average dye-loading of 2.20 CF633 per mole of antibody. The signal strength was comparable to the original DyLight 649 secondary after slight adjustment to the fluorescent scanner PMT settings.
All secondary antibodies were stored at 4 °C up to 6 months. We prepared a second batch of each dye-labeled secondary antibody and compared them with those used for the experiments in this paper.
We evaluated two factors: signal correlation between the antibody batches and median signal for a subset of microarray glycans (termed the 'normalization set'). For example, the second AlexaFluor488 conjugation gave us dye-loading of 0.90. When we compared the signal with the original 1.0 loading, the linear correlation was 0.99, showing that the secondary antibodies bound the same array components. We performed the same comparison between our original 1.5-loaded anti-IgG and a new 1.4 secondary antibody. The correlation between secondary antibodies was 0.96 with a linear slope of 0.96.
Bleed-through:
Bleed-through with low loaded dyes was very low. The anti-IgG secondary reagent had no measurable bleed-through into the 635 nm channel. The anti-IgA secondary reagent S4 loaded with 1.0 dyes per antibody molecule had bleed-through into the 532 nm channel of only 2.5%. To account for this amount of bleed-through, we could apply a correction factor such that we would reduce each glycan's 532 nm (IgG) signal by 2.5% of the IgA signal. From a practical point of view, this only becomes relevant if (A) the IgA signal for a particular array component is greater than 10,000 RFUs, and (B) the IgG signal is much lower than the IgA signal. This situation is rare, and to date we have not observed any instances where both criteria are satisfied. Therefore, for the vast majority of samples, no correction is necessary.
Testing other fluorophores:
One approach for minimizing dye-dye interaction was to vary the spectral properties of the dyes to minimize spectral overlap. We performed reference serum profiling experiments with FITC and Atto465-labeled anti-IgA. Unfortunately, we did not observe any improvements in signal loss. In addition, these dyes had much lower stability and signal strength relative to AlexaFluor488. Therefore, we remained with the AlexaFluor488 dye. We also evaluated alternative fluorophores for detection using the 532 nm laser. With AlexaFluor594, we observed large amounts of spillover/bleed-through from the 635 nm lasers. Cy3 produced the strongest signals using the 532 nm laser but also gave the greatest IgA signal loss. AlexaFluor546 gave strong signals, showed good stability, and had slightly less IgA signal loss than the DyLight549 and Cy3. Therefore, AlexaFluor546 was selected for the multiplex assay. Overall, however, varying the dyes led to only minor improvements. Figure S1 : Images of pre-and post-experimental array wells for the multiplex assay. A) Signals in the preexperimental images are from a 532-emitting fluorescent dye in the print buffer, which is later washed away during slide blocking. Blue boxes represent components that were missing during array printing. B) Array slides were incubated with human serum (1:50) and then all three secondary antibodies (1:500).
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A) Scatter plot of IgA signals in singleplex format vs multiplex before optimization.
B) IgA signal loss for multiplex relative to singleplex before optimization 2  17  32  47  62  77  94  110  125  140  155  170  185  200  215  230  245  260  275  290  305  320  335  350  365  380  395  410  425  440  455  470  485  500 IgA Signal Loss (%) S11 Figure S5 : Heat map showing changes for subjects 2-6. IgA, IgG, and IgM signals were measured on the glycan microarray at different time points for 7 subjects. Changes from one time point to another were determined. Representative data for Subjects 1 and 7 are shown in Figure 4 . Data for subjects 2-6 are presented in this figure.
White boxes indicate no change; pink boxes indicate an increase; blue boxes indicate decreases. The scale bar and coloring use a linear scale. Rows are labeled with the subject number.
